Biocon Ltd Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Biocon Ltd Quarterly Results    (BICN)

Here are the latest quarterly results of Biocon Ltd. For more details, see the Biocon Ltd financial fact sheet and Biocon Ltd share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Biocon Ltd Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-18
*
3
Jun-18
*
3
Sep-18
*
3
Dec-18
*
3
Mar-19
*
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m11,69511,23813,21015,4087,6394,80815,72217,481 
Other income Rs m675688544256139253384358 
Turnover Rs m12,37011,92613,75415,6647,7785,06116,10617,839 
Expenses Rs m9,3658,8609,81411,6016,6544,07411,69413,039 
Gross profit Rs m2,3812,3785,2843,8659851,5544,7034,442 
Depreciation Rs m9539911,1221,1673752401,3161,440 
Interest Rs m16917618818665138177 
Profit before tax Rs m1,9341,8994,5182,7687431,5623,6333,183 
Tax Rs m407521732461383421,001848 
Profit after tax Rs m1,5271,3783,7862,3077051,2202,6322,335 
Gross profit margin %20.421.240.025.112.932.329.925.4 
Effective tax rate %21.027.416.216.75.121.927.626.6 
Net profit margin %13.112.328.715.09.225.416.713.4 
Diluted EPS Rs 2.5 2.3 6.3 3.8 1.2 2.0 4.4 3.9  
Diluted EPS (TTM) Rs 6.6 7.3 12.6 15.0 13.6 13.4 11.4 11.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Biocon Ltd 3QFY20 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   DR. REDDYS LAB  CIPLA  WYETH LTD  GLENMARK PHARMA  CADILA HEALTHCARE  

Compare BIOCON With:   DR. REDDYS LAB  CIPLA  WYETH LTD  GLENMARK PHARMA  CADILA HEALTHCARE  

Compare BIOCON With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Falls 500 Points; Kotak Mahindra Bank & IndusInd Bank Top Losers(12:30 pm)

Share markets in India are presently trading on a negative note, as investors worried about the economic impact and uncertainty over the coronavirus pandemic.

Views on news

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020 (The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon (Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock (Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

Lockdown! Now the Bailout... (The Honest Truth)

Mar 25, 2020

Ajit Dayal on what India should do to manage the coronavirus impact on the economy.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 3, 2020 01:21 PM

TRACK BIOCON

MORE ON BIOCON

BIOCON - GSK PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS